Cargando…
Current Role of Delta Radiomics in Head and Neck Oncology
The latest developments in the management of head and neck cancer show an increasing trend in the implementation of novel approaches using artificial intelligence for better patient stratification and treatment-related risk evaluation. Radiomics, or the extraction of data from various imaging modali...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916410/ https://www.ncbi.nlm.nih.gov/pubmed/36768535 http://dx.doi.org/10.3390/ijms24032214 |
_version_ | 1784886119241875456 |
---|---|
author | Marcu, David C. Grava, Cristian Marcu, Loredana G. |
author_facet | Marcu, David C. Grava, Cristian Marcu, Loredana G. |
author_sort | Marcu, David C. |
collection | PubMed |
description | The latest developments in the management of head and neck cancer show an increasing trend in the implementation of novel approaches using artificial intelligence for better patient stratification and treatment-related risk evaluation. Radiomics, or the extraction of data from various imaging modalities, is a tool often used to evaluate specific features related to the tumour or normal tissue that are not identifiable by the naked eye and which can add value to existing clinical data. Furthermore, the assessment of feature variations from one time point to another based on subsequent images, known as delta radiomics, was shown to have even higher value for treatment-outcome prediction or patient stratification into risk categories. The information gathered from delta radiomics can, further, be used for decision making regarding treatment adaptation or other interventions found to be beneficial to the patient. The aim of this work is to collate the existing studies on delta radiomics in head and neck cancer and evaluate its role in tumour response and normal-tissue toxicity predictions alike. Moreover, this work also highlights the role of holomics, which brings under the same umbrella clinical and radiomic features, for a more complex patient characterization and treatment optimisation. |
format | Online Article Text |
id | pubmed-9916410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99164102023-02-11 Current Role of Delta Radiomics in Head and Neck Oncology Marcu, David C. Grava, Cristian Marcu, Loredana G. Int J Mol Sci Review The latest developments in the management of head and neck cancer show an increasing trend in the implementation of novel approaches using artificial intelligence for better patient stratification and treatment-related risk evaluation. Radiomics, or the extraction of data from various imaging modalities, is a tool often used to evaluate specific features related to the tumour or normal tissue that are not identifiable by the naked eye and which can add value to existing clinical data. Furthermore, the assessment of feature variations from one time point to another based on subsequent images, known as delta radiomics, was shown to have even higher value for treatment-outcome prediction or patient stratification into risk categories. The information gathered from delta radiomics can, further, be used for decision making regarding treatment adaptation or other interventions found to be beneficial to the patient. The aim of this work is to collate the existing studies on delta radiomics in head and neck cancer and evaluate its role in tumour response and normal-tissue toxicity predictions alike. Moreover, this work also highlights the role of holomics, which brings under the same umbrella clinical and radiomic features, for a more complex patient characterization and treatment optimisation. MDPI 2023-01-22 /pmc/articles/PMC9916410/ /pubmed/36768535 http://dx.doi.org/10.3390/ijms24032214 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Marcu, David C. Grava, Cristian Marcu, Loredana G. Current Role of Delta Radiomics in Head and Neck Oncology |
title | Current Role of Delta Radiomics in Head and Neck Oncology |
title_full | Current Role of Delta Radiomics in Head and Neck Oncology |
title_fullStr | Current Role of Delta Radiomics in Head and Neck Oncology |
title_full_unstemmed | Current Role of Delta Radiomics in Head and Neck Oncology |
title_short | Current Role of Delta Radiomics in Head and Neck Oncology |
title_sort | current role of delta radiomics in head and neck oncology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916410/ https://www.ncbi.nlm.nih.gov/pubmed/36768535 http://dx.doi.org/10.3390/ijms24032214 |
work_keys_str_mv | AT marcudavidc currentroleofdeltaradiomicsinheadandneckoncology AT gravacristian currentroleofdeltaradiomicsinheadandneckoncology AT marculoredanag currentroleofdeltaradiomicsinheadandneckoncology |